 IM Cannabis NASDAQ:IMCC CSE:IMCC announced its unaudited financial results on Monday for the three and nine-month periods ended September 30, 2021, with revenues of CA14.4 million 11.5 million, a sequential increase of approximately 30. The international cannabis company with operations in Canada, Israel and Germany noted that revenues would have been 1.4 million higher had the acquisitions of MYM closed and if the Pharm Yarok and Vironna transactions signed at the start of the quarter had gone through. 